Simplex Trading
BEAM icon

Simplex Trading’s Beam Therapeutics BEAM Stock Holding History

Simplex Trading’s Portfolio BEAM Stock Details BEAM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.2K Sell
1,308
-7,494
-85% -$208K ﹤0.01% 6346
2025
Q4 		$244K Sell
8,802
-5,530
-39% -$141K ﹤0.01% 4023
2025
Q3 		$347K Sell
14,332
-42,238
-75% -$840K ﹤0.01% 4279
2025
Q2 		$962K Buy
56,570
+40,103
+244% +$698K ﹤0.01% 2821
2025
Q1 		$321K Buy
16,467
+10,571
+179% +$277K ﹤0.01% 3869
2024
Q4 		$146K Buy
+5,896
New +$150K ﹤0.01% 4810
2024
Q3 		– Sell
-12,417
Closed -$321K – 8477
2024
Q2 		$290K Buy
+12,417
New +$305K ﹤0.01% 4273
2023
Q4 		– Sell
-25,117
Closed -$624K – 8767
2023
Q3 		$604K Buy
25,117
+21,622
+619% +$580K ﹤0.01% 3204
2023
Q2 		$111K Sell
3,495
-18,523
-84% -$601K ﹤0.01% 4956
2023
Q1 		$674K Buy
22,018
+15,991
+265% +$631K ﹤0.01% 2968
2022
Q4 		$235K Buy
+6,027
New +$270K ﹤0.01% 4028
2022
Q3 		– Sell
-5,916
Closed -$337K – 9892
2022
Q2 		$229K Buy
+5,916
New +$235K ﹤0.01% 4444
2022
Q1 		– Sell
-415
Closed -$27.2K – 10382
2021
Q4 		$33K Buy
+415
New +$35.5K ﹤0.01% 7758

Other funds holding BEAM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

Simplex Trading's BEAM Position: Q1 2026 in Review

Simplex Trading reduced its Beam Therapeutics (BEAM) stake by 85% in Q1 2026, selling an estimated $208K and leaving 1,308 shares worth $31.2K. The position accounts for ﹤0.01% of the portfolio, ranked #6346.

Simplex Trading first reported a position in BEAM in Q4 2021 and has held it in 13 quarters since. The position peaked at $962K in Q2 2025. 251 funds tracked by Wall St. Rank hold BEAM as of Q1 2026.

  • Simplex Trading held 1,308 shares of Beam Therapeutics worth $31.2K as of Q1 2026.
  • Simplex Trading sold 7,494 Beam Therapeutics shares in Q1 2026, an estimated $208K.
  • Beam Therapeutics made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #6346 holding.
  • Simplex Trading first reported a position in Beam Therapeutics in Q4 2021 and has held it in 13 quarters since.
  • Simplex Trading's Beam Therapeutics position peaked at $962K in Q2 2025.
  • 251 funds tracked by Wall St. Rank held Beam Therapeutics as of Q1 2026.

Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.